» Authors » Stan Rosenfeld

Stan Rosenfeld

Explore the profile of Stan Rosenfeld including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 1469
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schaeffer E, Srinivas S, Adra N, An Y, Bitting R, Chapin B, et al.
J Natl Compr Canc Netw . 2024 Apr; 22(3):140-150. PMID: 38626801
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic...
2.
Schaeffer E, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al.
J Natl Compr Canc Netw . 2023 Oct; 21(10):1067-1096. PMID: 37856213
The NCCN Guidelines for Prostate Cancer provide a framework on which to base decisions regarding the workup of patients with prostate cancer, risk stratification and management of localized disease, post-treatment...
3.
Schaeffer E, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al.
J Natl Compr Canc Netw . 2022 Dec; 20(12):1288-1298. PMID: 36509074
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate...
4.
Schaeffer E, Srinivas S, Antonarakis E, Armstrong A, Bekelman J, Cheng H, et al.
J Natl Compr Canc Netw . 2021 Feb; 19(2):134-143. PMID: 33545689
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease. Recommendations for disease monitoring...
5.
Belkora J, Chan J, Cooperberg M, Neuhaus J, Stupar L, Weinberg T, et al.
Cancer Med . 2019 Nov; 9(1):125-132. PMID: 31714037
Objectives: Development and pilot evaluation of a personalized decision support intervention to help men with early-stage prostate cancer choose among active surveillance, surgery, and radiation. Methods: We developed a decision...
6.
Mohler J, Antonarakis E, Armstrong A, DAmico A, Davis B, Dorff T, et al.
J Natl Compr Canc Netw . 2019 May; 17(5):479-505. PMID: 31085757
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat...
7.
Mohler J, Armstrong A, Bahnson R, DAmico A, Davis B, Eastham J, et al.
J Natl Compr Canc Netw . 2016 Jan; 14(1):19-30. PMID: 26733552
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease...
8.
Mohler J, Kantoff P, Armstrong A, Bahnson R, Cohen M, DAmico A, et al.
J Natl Compr Canc Netw . 2014 May; 12(5):686-718. PMID: 24812137
Prostate cancer has surpassed lung cancer as the most common cancer in men in the United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management...
9.
Mohler J, Kantoff P, Armstrong A, Bahnson R, Cohen M, DAmico A, et al.
J Natl Compr Canc Netw . 2013 Dec; 11(12):1471-9. PMID: 24335682
The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer. This report highlights notable recent updates. Radium-223 dichloride is a first-in-class radiopharmaceutical...
10.
Mohler J, Armstrong A, Bahnson R, Boston B, Busby J, DAmico A, et al.
J Natl Compr Canc Netw . 2012 Sep; 10(9):1081-7. PMID: 22956807
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer provide multidisciplinary recommendations for the clinical management of patients with prostate cancer. These NCCN Guidelines Insights highlight notable...